≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Eosinophilia

DOID Endpoint Browser

D3_EOSINOPHILIA

Hypereosinophilic syndrome: The hypereosinophilic syndrome (HES) is a disease characterized by a persistently elevated eosinophil count (≥ 1500 eosinophils/mm³) in the blood for at least six months without any recognizable cause, with involvement of either the heart, nervous system, or bone marrow. HES is a diagnosis of exclusion, after clonal eosinophilia (such as leukemia) and reactive eosinophilia (in response to infection, autoimmune disease, atopy, hypoadrenalism, tropical eosinophilia, or cancer) have been ruled out.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D72.1
  • Hospital discharge: ICD-9 — 2883
  • Cause of death: ICD-10 — D72.1
  • Cause of death: ICD-9 — 2883

2 out of 7 registries used, show all original rules.

569

4. Check minimum number of events

None

569

5. Include endpoints

None

569

6. Filter based on genotype QC (FinnGen only)

569

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D72
Name in latin
Eosinophilia

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 569 302 267
Unadjusted period prevalence (%) 0.11 0.10 0.12
Median age at first event (years) 56.84 52.68 61.55

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
503
Matched controls
5027
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D72.1
ICD-10 Finland
Eosinophilia
4503599627370496.0
323.0
490
*
H02AB06
ATC
prednisolone; systemic
5.4
66.3
359
1594
XW000
NOMESCO Finland
Bone marrow biopsy
20.9
59.0
89
51
J45.9
ICD-10 Finland
Asthma, unspecified
5.6
55.5
196
513
J45.1
ICD-10 Finland
Nonallergic asthma
9.7
54.8
119
155
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.0
48.8
194
565
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
47.2
315
1482
J32.4
ICD-10 Finland
Chronic pansinusitis
32.6
44.2
58
20
R03DC03
ATC
montelukast; oral
5.0
42.8
163
443
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.4
39.5
114
221
R03AK08
ATC
formoterol and beclometasone; inhalant
12.7
37.3
68
61
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
9.3
37.3
81
102
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.8
35.8
87
131
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
360.2
34.3
34
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
13.8
33.7
59
48
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
348.7
33.3
33
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
32.8
226
991
R03AC02
ATC
salbutamol; inhalant
3.1
32.2
328
1884
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
13.9
31.6
55
44
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
7.9
31.5
75
109
R03BB04
ATC
tiotropium bromide; inhalant
5.3
31.3
104
235
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.9
31.0
93
186
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
12.7
31.0
56
49
XG474
NOMESCO Finland
Exhalation nntrogen oxide
11.7
28.8
54
51
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.2
28.2
80
148
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.8
24.8
120
385
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
71.0
24.0
27
*
ZXE00
NOMESCO Finland
One hour or less
2.6
23.0
246
1342
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.9
22.9
79
183
R01AD08
ATC
fluticasone; nasal
2.8
22.8
194
925
R03BA05
ATC
fluticasone; inhalant
3.2
22.7
139
532
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
22.3
111
363
J45
ICD-10 Finland
Asthma
4.3
21.8
87
233
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
21.7
155
655
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
21.3
85
228
DHB20
NOMESCO Finland
Polypectomy of internal nose
17.6
21.2
33
20
R03BA08
ATC
ciclesonide; inhalant
4.5
20.9
79
201
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.1
19.8
49
75
R01AD09
ATC
mometasone; nasal
2.4
19.5
262
1569
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.6
19.4
46
66
XQ800
NOMESCO Finland
Prick test
4.6
19.3
70
170
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
19.1
85
250
R50.9
ICD-10 Finland
Fever, unspecified
3.3
18.9
107
379
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
18.8
290
1848
WZC30
NOMESCO Finland
Teaching
3.4
18.5
101
350
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
18.3
77
216
H02AB04
ATC
methylprednisolone; systemic
3.1
17.6
110
420
TGC00
NOMESCO Finland
Bronchial lavation
9.4
17.5
36
41
A02BC02
ATC
pantoprazole; systemic
2.3
17.3
348
2471
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
6.4
17.3
46
78
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
17.0
66
171
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.7
16.8
135
603
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.0
16.7
38
51
J01MA12
ATC
levofloxacin; systemic
2.8
16.7
121
507
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.2
16.6
45
78
R06AE07
ATC
cetirizine; oral
2.2
16.5
246
1508
J33.8
ICD-10 Finland
Other polyp of sinus
9.7
16.4
33
36
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
15.7
174
918
J46
ICD-10 Finland
Status asthmaticus
6.7
15.7
40
64
H02AB07
ATC
prednisone; oral
2.9
15.6
103
405
R03AC13
ATC
formoterol; inhalant
5.3
15.5
48
98
J01MA14
ATC
moxifloxacin; systemic
3.7
15.3
69
205
R03AK07
ATC
formoterol and budesonide; inhalant
2.6
15.1
126
570
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.5
14.9
133
623
R96
ICPC
Asthma
3.6
14.8
69
210
A02BC01
ATC
omeprazole; systemic
2.3
14.7
166
876
J45.8
ICD-10 Finland
Mixed asthma
5.9
14.2
40
73
R03AC12
ATC
salmeterol; inhalant
4.9
14.0
46
101
J01AA02
ATC
doxycycline; systemic
2.3
13.8
395
3107
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.4
13.7
41
81
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
13.7
203
1209
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
77.3
13.6
15
*
R01AD12
ATC
fluticasone furoate; nasal
2.2
13.6
176
986
DPA30
NOMESCO Finland
Sphenotomy
18.9
13.5
20
11
ZX112
NOMESCO Finland
Subcutaneous
7.9
13.4
30
40
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
13.3
117
539
R03BA01
ATC
beclometasone; inhalant
2.8
13.0
94
387
WX002
NOMESCO Finland
Sedation and analgesia
2.4
13.0
120
570
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
12.8
61
189
H02AB09
ATC
hydrocortisone; systemic
7.3
12.8
30
43
M05BA04
ATC
alendronic acid; oral
3.6
12.7
58
174
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
12.7
93
387
2883X
ICD-9 Finland
Diseases of white blood cells, Eosinophilia[EOSINOPHILIA, NUD]
+∞
12.5
12
*
XG410
NOMESCO Finland
Flow-volume spirometry
5.0
12.2
39
83
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
12.2
106
483
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
16.4
12.2
19
12
J33.9
ICD-10 Finland
Nasal polyp, unspecified
16.4
12.2
19
12
J47
ICD-10 Finland
Bronchiectasis
12.8
12.2
21
17
R05
ICD-10 Finland
Cough
2.4
12.1
121
595
E0000UV
ATC
NA
2.0
12.0
212
1337
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.5
11.9
100
449
R03AK11
ATC
formoterol and fluticasone; inhalant
5.6
11.9
34
64
3028
Kela drug reimbursment
Mepolizumab
66.5
11.7
13
*
R03DX09
ATC
mepolizumab; parenteral
122.7
11.5
12
*
C03CA01
ATC
furosemide; systemic
2.2
11.4
142
772
R03DC01
ATC
zafirlukast; oral
8.6
11.4
24
29
J01DB01
ATC
cefalexin; oral
2.2
11.2
413
3411
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.3
11.2
41
101
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
20.6
11.2
16
8
R06AE09
ATC
levocetirizine; oral
2.5
11.0
92
410
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
28.7
10.8
14
5
JN4BD
NOMESCO Finland
Extensive body CT
2.7
10.7
74
297
297
Kela drug reimbursment
NA
61.3
10.7
12
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
10.4
68
263
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.4
10.1
49
155
R06.0
ICD-10 Finland
Dyspnoea
2.1
10.0
136
761
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
9.8
47
147
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.4
9.7
46
143
D07AC01
ATC
betamethasone; topical
1.9
9.7
180
1137
ZXA10
NOMESCO Finland
Bilateral
2.2
9.6
108
556
R01AD01
ATC
beclometasone; nasal
2.4
9.6
88
409
L29.9
ICD-10 Finland
Pruritus, unspecified
7.4
9.6
22
31
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.3
9.5
28
55
J01FF01
ATC
clindamycin; systemic
2.0
9.5
147
864
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
9.5
94
455
R03BA02
ATC
budesonide; inhalant
2.2
9.4
102
516
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
9.3
34
84
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
9.3
61
235
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.9
9.1
56
209
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.5
9.0
42
129
R06AX27
ATC
desloratadine; oral
1.9
8.9
147
883
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
8.8
115
628
J31.0
ICD-10 Finland
Chronic rhinitis
2.9
8.8
54
200
UJF32
NOMESCO Finland
Coloscopy
2.0
8.7
135
793
R06AX22
ATC
ebastine; oral
2.2
8.7
93
466
L04AA06
ATC
mycophenolic acid; systemic
8.4
8.6
18
22
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
16.6
8.6
13
8
R03DA04
ATC
theophylline; systemic, rectal
3.4
8.6
41
129
Z3231
NOMESCO Finland
Registered nurse
1.9
8.2
139
839
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.1
8.1
16
18
J01CA04
ATC
amoxicillin; systemic
1.9
8.1
400
3387
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
10.3
8.1
15
15
J01FA06
ATC
roxithromycin; oral
1.8
8.0
200
1372
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.0
210
1465
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.0
7.9
109
605
J01FA09
ATC
clarithromycin; systemic
1.8
7.9
166
1079
S97
ICPC
Chronic ulcer skin
3.4
7.8
36
110
A02BC05
ATC
esomeprazole; systemic
1.8
7.8
196
1343
D07AD01
ATC
clobetasol; topical
2.2
7.8
86
438
R01AD11
ATC
triamcinolone; nasal
2.7
7.7
52
204
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
7.7
56
231
B01AA03
ATC
warfarin; systemic
2.1
7.7
98
528
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
25.4
7.6
10
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
7.6
55
227
UDM02
NOMESCO Finland
Sinoscopy
5.2
7.5
22
44
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.2
7.5
22
44
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.5
180
1215
C07AB07
ATC
bisoprolol; oral
1.7
7.4
223
1605
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
7.4
60
264
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
8.5
7.4
15
18
J01FA10
ATC
azithromycin; systemic
1.7
7.4
285
2203
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.3
7.3
36
116
3027
Kela drug reimbursment
Benralizumab
+∞
7.3
7
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
7.3
50
200
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
5.9
7.3
19
33
UDC00
NOMESCO Finland
Ear microscopy
2.8
7.3
44
164
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
7.3
61
271
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
16.0
7.3
11
7
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.2
116
684
D02AE01
ATC
carbamide; topical
3.0
7.2
41
145
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.4
7.1
20
38
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.8
7.1
22
47
L04AX01
ATC
azathioprine; systemic
3.6
7.0
30
87
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
7.0
57
249
R03AC03
ATC
terbutaline; inhalant
2.1
7.0
80
411
D07AC13
ATC
mometasone; topical
1.8
7.0
146
939
R06AX13
ATC
loratadine; oral
2.1
6.9
83
437
XG405
NOMESCO Finland
Education on PEF monitoring
8.4
6.9
14
17
B03XA02
ATC
darbepoetin alfa; parenteral
5.8
6.8
18
32
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.8
6.8
21
45
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.8
209
1506
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.3
6.7
19
37
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.6
6.7
16
25
SPAT1254
SPAT
Administration of medicine
2.1
6.6
77
399
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.6
200
1430
L50.9
ICD-10 Finland
Urticaria, unspecified
3.8
6.6
26
71
L28.1
ICD-10 Finland
Prurigo nodularis
10.2
6.6
12
12
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
6.6
104
609
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.9
6.5
38
138
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
6.5
48
198
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.6
6.5
28
82
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.4
6.5
18
34
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.8
6.5
17
30
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
6.5
48
200
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
6.4
66
326
WW200
NOMESCO Finland
Immunization
4.7
6.3
20
44
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.8
6.3
38
142
A46
ICD-10 Finland
Erysipelas
2.1
6.3
71
365
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
6.3
30
96
B44.8
ICD-10 Finland
Other forms of aspergillosis
+∞
6.3
6
*
I42.3
ICD-10 Finland
Endomyocardial (eosinophilic) disease
+∞
6.3
6
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.1
6.2
22
55
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.4
6.1
52
234
R01AD05
ATC
budesonide; nasal
2.4
6.1
50
222
L01XX05
ATC
hydroxycarbamide; oral
12.7
6.1
10
8
SPAT1263
SPAT
Sampling
1.6
6.1
205
1498
R06.2
ICD-10 Finland
Wheezing
3.1
6.1
31
104
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.7
6.1
12
14
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
10.2
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
247
276
15.05
218.59
2.8
1.2
u/ml
631.6
254.5
1.64
238
256
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
147
162
11.89
126.89
2.0
1.6
titre
92.0
220.0
—
10
7
(3003327) Ova and parasites identified in Stool by Light microscopy
132
148
11.31
111.92
2.2
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
89
72
14.47
92.80
2.0
1.7
g/l
1.7
0.8
1.85
66
56
(3030905) Polymorphonuclear cells [#/volume] in Blood
87
84
12.05
80.91
3.9
3.0
e9/l
4.9
4.2
1.30
87
84
(3005719) IgG [Mass/volume] in Serum or Plasma
171
368
6.21
80.12
3.4
2.4
g/l
10.4
10.4
0.05
156
333
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
87
86
11.76
79.61
4.2
3.4
%
56.2
58.2
0.55
87
86
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
99
121
9.69
77.65
1.6
2.0
mg/l
11.5
11.9
0.12
91
112
(42870588) Differential panel, method unspecified - Blood
369
1536
4.99
77.01
13.1
6.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
120
188
7.82
76.49
1.6
2.1
u/l
43.2
39.1
0.87
111
169
(21494434) Karyotype in Bone marrow
63
42
16.74
72.73
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
162
361
5.88
72.54
5.6
4.3
%
0.0
0.2
1.64
60
107
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
82
87
10.84
71.24
1.8
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
156
344
5.87
70.51
5.4
4.1
%
0.4
0.4
0.05
54
84
(3006504) Eosinophils/100 leukocytes in Blood
438
2173
5.41
70.51
14.4
5.9
%
6.9
2.8
25.02
425
2032
(3017181) Myelocytes/100 leukocytes in Blood
165
384
5.64
70.24
5.7
4.2
%
0.5
1.0
1.85
62
118
(3022096) Basophils/100 leukocytes in Blood
430
2108
5.26
70.15
14.3
6.0
%
0.8
0.7
6.61
418
1974
(3019069) Monocytes/100 leukocytes in Blood
438
2184
5.37
69.73
14.7
6.2
%
8.5
8.6
0.25
426
2056
(3006315) Basophils [#/volume] in Blood
453
2321
5.67
69.61
14.1
5.8
e9/l
0.1
0.0
12.29
432
2020
(3001604) Monocytes [#/volume] in Blood
450
2312
5.53
68.37
14.2
5.8
e9/l
0.6
0.6
7.62
428
2006
(3002030) Lymphocytes/100 leukocytes in Blood
443
2249
5.38
68.33
14.4
6.0
%
25.1
27.7
6.30
429
2110
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
188
502
5.10
67.97
4.8
4.1
u/l
258.1
243.0
0.37
182
477
(3013115) Eosinophils [#/volume] in Blood
457
2397
5.61
67.05
15.3
6.2
e9/l
0.5
0.2
26.19
435
2125
(3028026) IgM [Mass/volume] in Serum or Plasma
142
303
5.91
66.24
1.8
1.6
g/l
1.1
1.4
1.15
130
279
(3019198) Lymphocytes [#/volume] in Blood
454
2386
5.47
65.95
14.1
5.9
e9/l
1.9
2.0
0.35
434
2123
(3018010) Neutrophils/100 leukocytes in Blood
436
2222
5.12
65.91
13.5
5.9
%
55.2
57.3
2.82
422
2095
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
54
33
17.97
64.99
1.8
1.2
u/ml
7.2
0.3
1.13
23
18
(3025159) Blasts/100 leukocytes in Blood
149
338
5.62
64.89
5.9
4.4
%
0.1
0.1
0.18
53
90
(3042111) Morphology [Interpretation] in Bone marrow Narrative
65
65
11.16
58.59
1.2
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
204
647
4.36
58.16
1.5
1.3
titre
524.8
472.6
0.16
50
141
(3045142) Bone marrow Pathology biopsy report
55
44
13.73
57.13
1.1
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
53
42
13.81
55.33
1.6
1.2
g/l
3.0
2.7
0.38
37
29
(3024139) IgG subclass 3 [Mass/volume] in Serum
53
42
13.81
55.33
1.6
1.2
g/l
0.4
0.4
0.07
38
30
(3027135) IgG subclass 1 [Mass/volume] in Serum
53
42
13.81
55.33
1.6
1.2
g/l
6.9
7.2
0.15
38
30
(3036481) Cortisol [Moles/volume] in Serum or Plasma
157
427
4.70
54.36
3.2
2.1
nmol/l
316.8
370.7
2.87
152
394
(4062490)
53
44
13.18
53.79
1.6
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
256
1041
3.65
49.65
9.9
4.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
455
2680
4.48
49.52
16.3
9.1
e9/l
4.5
4.1
2.00
440
2366
(3027945) Reticulocytes/100 erythrocytes in Blood
163
498
4.19
47.88
2.7
2.8
%
1.8
1.8
0.03
147
457
(3004588) Protein electrophoresis panel - Serum or Plasma
118
285
4.96
46.83
2.2
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
125
353
4.26
40.32
2.2
2.7
g/l
65.2
66.5
1.05
113
323
(3023520) Reticulocytes [#/volume] in Blood
127
371
4.12
39.04
2.5
2.6
e9/l
65.3
69.8
0.94
99
285
(3021589) Normoblasts [#/volume] in Blood
366
2067
3.16
38.01
19.2
9.3
e9/l
0.0
0.0
0.47
328
1700
(40761536) Microorganisms panel - Urine sediment
127
382
3.99
37.38
4.9
3.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
215
952
3.02
33.71
1.9
1.4
g/l
2.2
2.4
1.46
162
586
(46235355) HIV 1 and 2 tests - Meaningful Use set
201
859
3.07
33.55
1.8
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
268
1348
2.87
33.06
6.5
4.0
ph
7.4
7.4
0.39
88
243
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
162
630
3.20
31.60
3.6
2.4
%
22.5
23.4
0.36
138
542
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
458
3.45
30.98
5.0
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
208
942
2.90
30.84
3.2
2.6
e6/l
4.6
4.9
0.12
187
828
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
35
37
10.01
30.01
1.3
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
35
37
10.01
30.01
1.3
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
164
663
3.07
29.72
3.5
2.4
g/l
2.3
2.3
0.50
154
616
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
389
2458
2.84
29.63
7.1
6.1
umol/l
10.0
11.4
3.31
382
2329
(40760888) Immunoglobulin light chains.free panel - Serum
53
93
6.18
29.51
2.4
4.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
484
3469
3.65
28.96
8.2
4.0
mm/h
14.5
12.0
2.56
460
3181
(1616796) Gas panel - Central venous blood
49
82
6.44
28.58
5.6
3.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
61
127
5.26
28.30
2.5
3.8
mg/l
44.1
99.8
0.60
39
106
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
61
127
5.26
28.30
2.5
3.9
mg/l
35.7
31.4
0.29
39
106
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
362
2239
2.70
28.18
10.5
7.2
mmol/l
1.2
1.2
0.26
273
1907
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
340
2059
2.62
27.32
9.6
6.5
mmol/l
1.2
1.2
0.19
315
1865
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
315
1842
2.59
27.20
3.0
2.3
nmol/l
77.9
76.2
0.48
295
1644
(3012501) Base excess in Blood by calculation
50
90
5.99
27.10
6.6
3.4
mmol/l
2.4
2.2
0.10
35
54
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
489
3599
3.55
26.44
11.9
7.3
u/l
77.4
78.3
0.21
475
3370
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
107
358
3.45
26.31
5.1
3.1
mmol/l
1.2
1.2
0.49
95
315
(3026782) Osmolality of Urine
191
891
2.72
26.05
3.2
2.8
mosm/kgh2o
559.1
564.5
0.12
171
762
(3011412) CD3 cells [#/volume] in Blood
32
37
9.10
25.63
1.7
2.0
e9/l
1.2
0.8
0.70
15
18
(3023368) Bacteria identified in Blood by Culture
235
1230
2.55
25.16
7.2
4.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
319
1925
2.50
25.05
6.4
4.8
g/l
33.5
35.6
7.76
292
1804
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
35
47
7.87
24.87
1.9
1.7
pg
33.0
33.4
0.22
35
47
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
15
15.22
24.62
1.3
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
140
572
2.92
24.40
9.2
6.4
mmol/l
1.1
1.0
0.79
132
531
(3022948) Iron [Moles/volume] in Serum or Plasma
164
730
2.75
24.30
3.6
2.4
umol/l
12.2
13.1
0.96
153
676
(3015171) Extractable nuclear Ab [Units/volume] in Serum
69
181
4.20
24.05
1.3
1.2
u/ml
0.2
3.4
—
7
8
(3004809) Band form neutrophils/100 leukocytes in Blood
40
65
6.54
23.95
4.4
3.2
%
0.8
1.6
0.51
34
56
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
156
4.42
23.66
1.8
2.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
160
715
2.72
23.42
4.5
3.9
mmol/l
0.8
0.8
0.62
149
674
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
27
5
56.54
23.25
1.1
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
163
744
2.67
22.81
2.0
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
133
548
2.86
22.67
2.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
558
2.81
21.85
1.7
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
39
69
5.99
21.45
2.9
2.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
20
15
13.78
21.19
5.3
5.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
307
1914
2.31
21.14
13.7
8.8
inr
1.3
1.2
0.57
143
546
(36304419) Bacteria [Presence] in Urine
225
1238
2.35
20.70
3.7
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
245
1400
2.32
20.62
3.9
3.2
e6/l
15.3
108.0
1.27
210
1071
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
99
4.97
20.45
1.4
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
274
1653
2.27
20.12
4.0
3.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
171
3.95
20.11
2.4
1.8
g/l
3.7
3.7
0.02
40
125
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
171
3.95
20.11
2.4
1.8
g/l
7.4
7.4
0.05
42
132
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
171
3.95
20.11
2.4
1.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
42
85
5.26
20.02
2.8
2.5
%
16.6
15.9
0.36
23
44
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
288
1778
2.26
19.94
5.4
3.6
ng/l
41.5
58.2
0.35
208
1240
(3030467) Casts [#/volume] in Urine by Automated count
228
1279
2.31
19.88
3.8
3.2
e6/l
0.2
0.5
3.83
195
952
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
24
9.94
19.78
1.6
2.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
19
15
13.07
19.52
1.4
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
92
4.97
19.24
2.0
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
158
3.97
19.13
2.4
1.8
g/l
10.2
10.6
0.21
44
139
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
31
49
6.63
19.01
1.9
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
159
3.95
18.96
2.3
1.8
g/l
3.3
3.2
0.20
41
128
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
25
31
8.39
18.90
1.6
2.0
e9/l
0.2
0.2
0.57
18
26
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
83
5.11
18.53
1.8
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
25
32
8.13
18.42
1.6
2.0
e6/l
343.4
426.7
0.49
18
26
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
19
10.87
18.31
1.7
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
80
5.16
18.30
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
80
5.16
18.30
1.5
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
43
97
4.71
18.07
1.6
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
127
569
2.59
18.03
2.3
2.4
ug/g
145.9
117.4
0.27
108
453
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
30
8.31
18.01
1.9
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
149
724
2.43
17.76
1.7
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
20
10.33
17.68
1.7
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
266
1646
2.16
17.68
4.5
3.8
e6/l
66.1
70.4
0.05
222
1157
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
65
203
3.49
17.54
1.6
2.1
g/l
1.6
1.5
0.20
54
175
(3015377) Calcium [Moles/volume] in Serum or Plasma
251
1523
2.16
17.50
2.9
3.3
mmol/l
2.3
2.3
3.13
226
1336
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
192
1053
2.24
17.20
1.5
1.3
u/ml
0.6
1.7
1.60
55
272
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
101
4.52
17.19
1.6
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
133
622
2.49
17.18
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
88
335
2.92
17.06
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
152
3.82
16.98
1.5
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
24
9.05
16.87
1.6
2.3
%
8.6
10.6
0.38
11
17
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
50
134
3.99
16.84
2.5
1.9
g/l
0.0
0.0
0.50
42
127
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
78
5.00
16.82
1.0
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
225
1325
2.15
16.78
4.1
3.1
ng/l
2205.3
1209.3
0.79
202
1151
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
117
4.19
16.61
1.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
116
518
2.56
16.47
1.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
151
3.77
16.38
2.1
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
380
2743
2.16
16.37
6.8
4.8
mmol/l
6.7
6.7
0.10
364
2555
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
25
8.68
16.35
2.0
1.6
u/ml
957.6
860.2
0.18
21
25
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
116
520
2.55
16.33
1.9
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
95
386
2.75
16.28
11.4
8.3
mmol/l
11.4
9.9
1.16
89
371
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
52
147
3.79
16.25
2.4
2.0
g/l
0.5
1.0
0.53
43
134
(40768443) Skin Pathology biopsy report
63
207
3.30
15.67
1.6
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
40
96
4.41
15.56
1.4
1.5
u/ml
238.3
255.3
0.13
27
56
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
105
4.24
15.51
1.4
1.4
—
—
—
0
0
(44813793)
21
27
8.04
15.38
1.1
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
124
3.95
15.36
2.5
1.9
g/l
0.0
0.0
0.00
38
117
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
12
12.81
15.19
1.0
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
200
1162
2.11
15.13
12.3
7.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
25
40
6.49
15.13
1.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
226
1376
2.07
15.07
3.2
2.1
u/l
141.6
273.1
1.48
212
1289
(3026493) Urate [Moles/volume] in Serum or Plasma
200
1164
2.11
15.05
3.2
2.8
umol/l
1597.3
7400.8
2.33
184
1005
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
101
440
2.58
15.01
2.1
2.4
g/l
0.2
0.2
0.38
94
411
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
25
8.26
14.97
1.7
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
45
122
3.92
14.90
2.6
1.9
g/l
0.0
0.0
0.00
38
116
(3041096) Erythrocytes [Presence] in Urine by Automated
213
1275
2.07
14.82
4.3
3.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
43
114
4.00
14.68
1.9
1.7
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
14
0
+∞
14.64
1.0
0.0
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
48
139
3.68
14.47
2.5
1.8
g/l
36.2
37.7
0.89
38
123
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
60
5.22
14.46
1.7
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
50
149
3.58
14.45
1.7
1.6
iu/ml
0.0
0.1
—
7
31
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
72
4.80
14.41
1.3
1.1
u/ml
0.4
2.1
1.12
19
29
(3029937) Albumin [Presence] in Urine by Test strip
207
1240
2.05
14.27
5.0
3.8
estimate
0.0
0.0
0.88
115
420
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
150
798
2.19
14.09
1.3
1.3
iu/ml
39.4
34.9
0.16
49
268
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
193
1134
2.06
13.97
3.1
2.1
mg/l
3.0
3.0
0.21
169
976
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
37
91
4.28
13.95
1.6
1.5
u/ml
120.1
99.1
—
7
15
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
62
5.05
13.94
1.2
1.1
u/ml
0.8
5.8
—
7
11
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
41
6.07
13.63
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
17
9.66
13.49
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
17
9.66
13.49
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
64
4.89
13.45
4.0
2.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
294
2031
1.93
13.11
4.4
2.7
ug/l
149.1
128.8
0.61
273
1866
(3042936) Bacteria identified in Isolate by Culture
129
664
2.22
13.05
2.2
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
232
1484
1.95
13.00
3.0
2.5
u/l
55.2
56.9
0.30
219
1374
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
66
4.74
12.97
1.8
1.6
—
—
—
0
0
(4035726)
91
404
2.49
12.91
1.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
416
3242
2.05
12.87
5.6
4.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
51
5.29
12.80
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
35
89
4.12
12.63
1.0
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
238
1548
1.92
12.59
3.9
3.3
u/l
41.6
32.8
0.39
227
1470
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
129
3.52
12.30
1.2
1.3
u/ml
6.9
2.7
—
7
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
43
130
3.50
12.16
1.3
1.3
u/ml
8.7
13.7
—
8
21
(3033658) Prothrombin time (PT) actual/Normal
188
1141
1.97
12.12
6.4
4.2
%
87.4
90.4
0.81
180
1116
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
83
4.16
12.08
1.6
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
40
5.68
11.73
1.2
1.2
u/l
195.7
68.9
0.38
15
27
(3022145) Colonoscopy Study observation
108
539
2.24
11.69
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
124
3.49
11.59
1.5
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
25
52
4.98
11.53
1.2
1.0
u/ml
7.0
2.0
—
10
14
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
56
4.82
11.52
5.3
3.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
76
327
2.53
11.47
2.2
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
319
2334
1.83
11.22
4.5
3.6
estimate
0.0
0.0
0.50
112
408
(3048879) Bone marrow aspiration report
12
11
11.12
11.09
1.6
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
533
4690
3.16
11.05
28.9
13.6
mg/l
20.6
23.7
1.72
477
3692
(3021601) Nitrite [Presence] in Urine by Test strip
315
2304
1.82
11.01
5.6
4.9
estimate
0.0
0.0
0.50
121
429
(3021901) Oxygen saturation in Capillary blood
31
81
3.99
10.80
2.5
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
436
3544
1.99
10.78
4.7
3.8
pmol/l
15.0
14.7
1.25
395
3196
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
135
759
2.02
10.65
1.3
1.3
u/ml
13.6
13.2
0.02
43
299
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
44
5.16
10.60
1.2
1.0
u/ml
1.4
7.7
—
7
13
(3035350) Ketones [Presence] in Urine by Test strip
313
2302
1.80
10.58
4.5
3.6
estimate
0.0
0.0
0.00
120
422
(3044927) Protein electrophoresis panel - Urine
23
48
4.95
10.57
1.2
1.1
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
10
0
+∞
10.45
1.0
0.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
79
3.95
10.34
3.2
2.8
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
15
8.85
10.26
1.7
3.0
e6/l
245.7
392.5
—
7
8
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
21
7.31
10.18
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
24
54
4.60
10.11
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
67
4.18
10.07
1.2
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
27
67
4.18
10.07
1.2
1.1
u/ml
1.3
6.4
1.36
15
36
(3000492) Spirometry study
88
428
2.25
10.06
1.8
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
147
3.08
9.99
1.5
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
468
3940
2.06
9.90
33.5
16.8
%
14.0
13.6
5.57
463
3873
(3008536) Aspergillus sp Ab [Presence] in Serum
12
13
9.41
9.90
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
25
6.56
9.86
1.5
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
36
5.43
9.70
1.6
2.0
e6/l
681.4
758.7
—
10
13
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
29
6.01
9.64
1.0
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
38
124
3.21
9.54
6.8
5.6
kpa
8.4
8.5
0.07
38
115
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
70
4.00
9.51
1.6
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
62
4.17
9.33
1.2
1.1
u/ml
0.4
0.5
0.09
13
28
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
145
872
1.89
9.26
6.0
3.6
ng/l
345.4
357.2
0.02
119
670
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
118
3.19
8.98
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
534
2.06
8.98
3.7
3.2
umol/l
7.5
8.5
0.21
79
461
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
153
947
1.84
8.88
1.8
1.7
pmol/l
120833740.4
6377980.3
0.46
120
784
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
163
1038
1.80
8.58
2.7
1.9
mg/l
1.4
1.3
0.21
128
797
(3000012) Reticulocyte production index
14
22
6.50
8.56
1.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
62
4.00
8.50
1.7
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
13
8.61
8.49
1.8
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
103
567
2.00
8.48
1.7
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
248
1782
1.69
8.47
4.8
3.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
385
3112
1.73
8.43
3.6
3.2
u/l
61.0
47.4
1.46
357
2911
(3000991) Gas panel - Venous blood
76
376
2.18
8.29
14.0
9.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
141
2.90
8.24
15.1
3.8
u/ml
0.4
0.4
0.20
27
74
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
18
38
4.86
8.16
1.6
1.3
%
31.3
28.0
0.11
11
26
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
64
3.87
8.15
1.4
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
33
109
3.15
8.14
1.2
1.2
u/ml
52.2
31.1
—
5
11
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
131
2.95
8.11
1.6
1.4
ug/g
274.3
284.0
0.09
20
77
(40765096) Chromosome analysis panel by Banding
11
14
7.99
8.01
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
33
111
3.09
7.90
1.4
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
24
5.96
7.89
1.7
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
14
24
5.96
7.89
1.9
2.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
8
15.28
7.74
1.7
1.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
376
3060
1.67
7.62
5.3
4.4
e6/l
95.3
2996.1
—
8
48
(3036489) Thrombin time
44
178
2.60
7.53
4.8
3.2
s
23.9
21.5
0.79
37
162
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
0
+∞
7.30
1.0
0.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
118
712
1.83
7.30
6.3
2.5
s
30.7
29.8
0.51
118
691
(3009508) Creatinine [Moles/volume] in Urine
206
1453
1.65
7.29
3.4
3.3
mmol/l
7.1
7.7
1.00
167
1212
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
56
262
2.26
6.99
2.6
3.4
pmol/l
4.6
4.6
0.05
45
233
(3002032) Base excess in Venous blood by calculation
81
438
1.99
6.97
5.7
4.6
mmol/l
1.3
2.0
0.74
64
346
(3004616) Nuclear Ab [Presence] in Serum
20
53
3.87
6.86
1.5
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
42
175
2.51
6.78
2.4
4.2
g/l
0.2
0.3
0.44
24
78
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
30
106
2.93
6.63
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
189
1332
1.63
6.58
3.4
3.3
mg/l
670.9
210.3
0.56
128
873
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
50
3.90
6.58
1.7
1.4
%
51.8
66.8
0.77
13
38
(3021447) Carbon dioxide [Partial pressure] in Venous blood
80
440
1.95
6.55
5.7
4.6
kpa
5.7
5.7
0.01
72
427
(3023103) Potassium [Moles/volume] in Serum or Plasma
526
4797
2.28
6.53
29.1
16.0
mmol/l
4.0
4.0
0.22
519
4660
(3035637) Corticotropin [Mass/volume] in Plasma
20
55
3.73
6.53
1.6
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
25
5.30
6.51
1.6
1.6
u/l
8.9
7.6
—
7
12
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
130
2.72
6.51
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
42
4.14
6.39
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
70
373
2.00
6.27
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
88
3.05
6.19
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
489
4372
1.84
6.06
24.5
12.4
ml/min/173m2
78.7
81.8
2.05
443
3586
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
44
3.95
6.02
1.1
1.0
u/ml
0.1
1.4
—
5
9
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
480
4274
1.79
5.95
5.7
4.6
mu/l
1.9
2.2
0.52
450
3888
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
36
4.25
5.85
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
13
28
4.73
5.76
1.8
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
125
817
1.68
5.75
2.0
1.7
nmol/l
1093.8
1185.4
0.57
94
625
(3052851) Hemolysis interference index of Serum or Plasma
32
127
2.61
5.72
5.1
2.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
17
5.97
5.64
2.4
4.1
u/l
213.1
206.9
—
10
17
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
241
1847
1.53
5.64
2.1
1.9
pmol/l
96.7
94.4
0.25
133
959
(3026008) Bacteria identified in Urine by Culture
189
1373
1.56
5.64
2.9
3.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
124
817
1.66
5.52
2.9
2.9
mmol/l
2.5
2.4
0.09
106
726
(3021788) Differential panel - Synovial fluid
23
78
3.03
5.47
1.7
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
383
3255
1.54
5.40
5.6
3.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
43
3.80
5.40
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
43
3.80
5.40
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
43
3.80
5.40
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
237
1829
1.51
5.27
2.4
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
44
3.71
5.24
1.3
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
317
1.96
5.17
6.6
4.8
mmol/l
1.7
1.7
0.05
46
242
(3021960) Folate [Moles/volume] in Serum or Plasma
151
1060
1.58
5.16
1.8
1.5
nmol/l
17.8
21.0
1.92
135
887
(3024354) Oxygen [Partial pressure] in Venous blood
66
371
1.88
5.06
3.9
4.0
kpa
4.6
4.7
0.15
59
360
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
228
2.11
5.02
14.5
10.2
mmol/l
24.6
24.5
0.08
41
214
(3020682) Albumin/Creatinine [Ratio] in Urine
189
1405
1.52
4.96
4.6
4.1
mg/mmol
16.2
11.0
0.44
124
897
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
32
4.13
4.92
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
32
4.13
4.92
1.1
1.1
—
—
—
0
0
(4010399)
62
345
1.89
4.90
1.9
1.4
—
—
—
0
0
(4306422)
20
69
2.97
4.64
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
59
330
1.88
4.60
6.7
4.7
ph
7.4
7.4
1.39
21
32
(3036048) Francisella tularensis Ab [Titer] in Serum
7
5
14.15
4.58
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
45
230
2.04
4.54
1.2
1.1
—
104.2
—
0
5
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
77
2.79
4.39
1.3
1.3
u/ml
2.1
5.3
—
7
26
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
13
35
3.78
4.39
1.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
22
4.61
4.32
1.4
1.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
26
108
2.47
4.28
1.2
1.8
mg/l
487.2
426.3
0.48
26
100
(3051651) Icteric interference index of Serum or Plasma
13
36
3.67
4.22
5.1
2.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
41
3.48
4.21
1.1
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.5
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.5
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.5
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
27
4.13
4.18
1.5
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
52
3.14
4.11
1.2
1.1
—
—
—
0
0
(3013512) EKG study
176
1335
1.46
4.05
4.9
3.8
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
7
10.10
4.02
1.7
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
7
10.10
4.02
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
1203
1.47
3.99
1.9
1.6
mmol/l
1.5
1.4
0.68
121
1009
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
28
3.99
3.99
1.4
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
28
3.99
3.99
1.4
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
273
1.87
3.89
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
334
1.79
3.85
6.2
4.4
ng/l
115.9
81.6
1.82
51
303
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
49
3.12
3.83
1.2
1.1
—
—
—
0
0
(4027681)
11
29
3.85
3.82
1.4
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
55
2.96
3.76
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
529
4980
1.89
3.75
17.7
10.2
u/l
25.9
26.5
0.46
522
4795
(3051611) Lipemic interference index of Serum or Plasma
14
45
3.16
3.67
5.6
2.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
30
3.72
3.65
1.4
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
30
3.72
3.65
1.4
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
208
1654
1.41
3.63
3.4
2.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
68
428
1.67
3.58
2.7
2.4
u/l
30.7
34.0
0.37
62
362
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
152
2.10
3.53
2.5
2.4
u/l
3706.2
2535.5
—
10
60
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
81
2.52
3.50
1.3
1.3
u/ml
4.2
7.1
—
9
37
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
58
2.81
3.44
1.2
1.2
nmol/l
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
19
76
2.55
3.41
1.6
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
42
3.14
3.39
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
79
524
1.59
3.38
10.4
8.7
mmol/l
0.9
1.4
0.50
55
413
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
121
2.20
3.37
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
77
2.52
3.33
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
77
2.52
3.33
1.6
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
54
2.83
3.27
1.2
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
15
54
2.83
3.27
10.6
7.0
mg/l
13.4
11.0
1.21
15
49
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
111
800
1.48
3.25
3.1
2.8
e6/l
0.6
1.0
1.57
68
459
(3025941) Bacteria identified in Stool by Culture
45
259
1.80
3.25
1.4
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
78
2.49
3.25
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
78
2.49
3.25
1.6
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
78
2.49
3.25
1.6
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
55
2.77
3.17
1.5
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
52
317
1.70
3.09
2.9
2.7
e9/l
4.4
4.0
0.72
44
249
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
12
5.89
3.03
1.3
2.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
21
4.34
3.00
1.2
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
21
4.34
3.00
1.4
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
21
4.34
3.00
1.4
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
21
4.34
3.00
1.1
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
75
2.45
2.99
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
63
2.58
2.98
1.1
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
77
525
1.54
2.93
10.8
8.6
kpa
5.0
5.1
0.54
71
506
(3027801) Oxygen [Partial pressure] in Arterial blood
77
525
1.54
2.93
10.7
8.6
kpa
11.6
12.0
0.44
71
508
(3011288) Drugs identified in Urine by Screen method
24
115
2.13
2.92
2.3
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
52
2.73
2.90
4.4
3.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
70
2.47
2.90
1.2
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
462
4269
1.44
2.88
6.6
5.8
mmol/mol
40.8
39.7
1.23
425
3956
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
342
3015
1.34
2.87
3.4
3.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
47
2.81
2.83
1.8
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
31
3.27
2.78
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
42
2.90
2.76
1.5
1.3
e6/l
10566.1
41984.0
—
7
21
(3013293) Extractable nuclear Ab [Presence] in Serum
6
10
6.05
2.70
1.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
79
2.32
2.70
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
59
386
1.59
2.69
2.6
2.4
ug/l
20.2
6.9
0.51
53
345
(40761511) CBC panel - Blood by Automated count
518
4914
1.60
2.68
23.7
12.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
32
3.16
2.65
1.4
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
32
3.16
2.65
1.4
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
127
2.01
2.64
1.6
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
277
1.68
2.61
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
66
447
1.54
2.60
1.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
49
309
1.64
2.60
3.7
6.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
39
231
1.74
2.60
2.5
2.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
25
3.64
2.58
1.3
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
81
2.26
2.56
1.3
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
44
2.76
2.56
1.6
2.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.19
2.55
1.6
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
187
1.81
2.55
2.3
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
56
2.54
2.55
2.4
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
258
2211
1.31
2.53
5.5
3.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
166
1.85
2.50
2.4
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
80
571
1.47
2.46
1.4
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
51
2.59
2.46
1.2
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
51
2.59
2.46
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
51
2.59
2.46
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
51
2.59
2.46
1.5
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
167
1.84
2.45
2.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
101
754
1.41
2.45
3.4
3.0
e6/l
1.7
2.0
0.18
58
416
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
110
2.04
2.44
1.4
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
168
1.83
2.41
2.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
30
168
1.83
2.41
2.4
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
12
5.04
2.40
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
64
2.38
2.40
1.5
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
327
1.58
2.31
1.3
1.2
iu/ml
96.3
162.1
0.65
19
125
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
18
3.92
2.26
1.1
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
17
80
2.16
2.20
4.1
2.7
%
61.9
64.0
0.13
17
80
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
43
276
1.60
2.16
1.9
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
19
3.72
2.15
1.7
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
19
3.72
2.15
2.6
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
246
1.63
2.10
17.5
11.8
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
10
5.03
2.07
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
541
5229
1.70
2.05
41.1
20.2
e9/l
270.2
248.4
10.82
535
5104
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
26
3.11
2.02
1.3
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
26
3.11
2.02
1.5
1.3
mmol/l
1.9
1.8
—
8
26
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
38
2.66
2.02
1.6
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
541
5233
1.69
1.99
41.1
20.1
e12/l
4.4
4.5
3.94
535
5095
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
134
1.83
1.98
2.0
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
541
5234
1.68
1.97
41.1
20.2
e9/l
7.9
6.8
14.70
535
5088
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
21
3.36
1.97
1.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
51
2.38
1.96
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
99
1.95
1.92
3.7
3.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
151
1.76
1.90
2.6
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
59
2.23
1.85
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
40
2.53
1.84
1.7
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
75
560
1.39
1.84
18.4
24.6
inr
1.0
1.3
3.25
12
74
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
12
4.19
1.82
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
174
1467
1.27
1.82
3.7
2.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
151
0.39
1.79
2.0
1.4
—
—
—
0
0
(4268621)
12
54
2.25
1.75
2.8
2.3
—
—
—
0
0
(3020891) Body temperature
29
179
1.65
1.73
3.1
4.8
—
—
—
0
0
(3019225) pH of Specimen
60
436
1.42
1.72
6.5
4.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
173
1.65
1.67
2.0
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
112
1.81
1.66
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
76
2.00
1.65
2.5
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
143
1.71
1.63
1.7
1.5
mu/l
465.9
287.5
0.96
19
130
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
26
2.71
1.58
1.1
1.1
iu/ml
314.4
192.8
—
7
26
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
474
4511
1.30
1.58
5.2
4.5
mmol/l
6.0
6.0
0.16
433
4097
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
50
2.22
1.58
2.4
2.6
nmol/l
3.4
6.8
0.51
11
50
(3009542) Hematocrit [Volume Fraction] of Blood
454
4298
1.28
1.57
29.4
14.8
%
39.2
39.9
1.00
322
3108
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
75
576
1.35
1.56
1.5
1.7
%
1.6
1.5
0.83
68
510
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
104
840
1.29
1.53
1.6
1.5
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
15
3.35
1.52
1.2
1.0
miu/ml
2388.0
1405.3
—
5
15
(3013637) Mi-2 Ab [Presence] in Serum
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
37
2.45
1.48
1.3
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
371
1.41
1.48
3.3
2.7
ml/min/173m2
51.2
67.1
2.41
25
152
(3023323) Follitropin [Units/volume] in Serum or Plasma
28
180
1.58
1.45
1.6
1.4
iu/l
26.9
25.7
0.05
19
154
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
488
4675
1.31
1.45
5.4
4.9
mmol/l
2.7
2.8
0.98
450
4285
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
451
1.37
1.44
1.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
66
1.99
1.44
1.4
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
40
2.27
1.40
1.3
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
46
2.19
1.40
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
119
1.71
1.39
3.0
2.3
ug/min
308.2
102.8
0.41
13
65
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
17
2.96
1.36
1.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
17
2.96
1.36
1.2
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
17
2.96
1.36
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
44
593
0.72
1.29
5.6
4.5
%
30.0
31.7
0.50
31
391
(44790047)
12
62
1.96
1.28
1.6
1.7
—
—
—
0
0
(44790049)
12
62
1.96
1.28
1.6
1.7
—
—
—
0
0
(44790048)
12
62
1.96
1.28
1.6
1.7
—
—
—
0
0
(44806118)
12
62
1.96
1.28
1.6
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
48
2.10
1.28
2.4
2.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
77
1.84
1.26
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
77
1.84
1.26
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
60
462
1.33
1.26
3.4
4.3
ug/l
108.2
31.8
0.36
49
384
(3035880) pH of Pleural fluid
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
35
246
1.45
1.24
3.7
2.8
e6/l
0.3
0.2
0.16
35
240
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
417
0.68
1.23
2.0
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
56
1.98
1.22
1.4
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
479
4601
1.26
1.22
5.0
4.4
mmol/l
4.6
4.6
0.68
443
4243
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
149
1.57
1.19
1.4
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
110
1.66
1.16
1.6
1.5
e6/l
18969.8
17590.2
0.04
13
85
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
150
1.56
1.16
1.4
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
20
2.51
1.15
1.8
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
65
1.86
1.14
1.5
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
14
81
1.75
1.10
2.6
3.1
nmol/l
0.6
1.0
—
9
64
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
219
1.44
1.09
1.5
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
154
1.51
1.05
1.4
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
221
1.43
1.05
1.6
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
46
1.97
1.04
1.3
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
1.2
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
34
2.07
1.03
2.9
2.8
%
8.5
11.7
—
7
34
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
44
568
0.76
1.00
6.1
6.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
429
0.73
0.95
1.2
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
296
1.34
0.94
1.9
2.7
—
—
—
0
0
(3036603) Volume of Urine
6
27
2.23
0.93
1.3
1.6
—
1897.1
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
27
2.23
0.93
1.2
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
78
1.68
0.92
1.6
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
28
2.15
0.91
1.2
1.4
g/l
0.8
1.1
—
6
28
(3045424) Erythrocytes [Presence] in Urine
14
86
1.64
0.91
1.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
94
1.61
0.91
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
225
0.66
0.83
1.5
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
11
65
1.71
0.83
1.5
2.6
umol/l
5.3
5.1
—
5
48
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
33
1.83
0.79
19.0
16.7
nmol/l
1838.3
1458.2
—
6
33
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
38
1.85
0.73
1.7
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
188
1.34
0.67
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
206
1.33
0.66
1.6
1.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
28
1.79
0.66
1.6
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
28
1.79
0.66
22.0
2.1
mg/l
55.8
101.2
—
5
22
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
470
4573
1.16
0.66
5.0
4.3
mmol/l
1.4
1.5
0.89
434
4191
(3003694) ABO and Rh group [Type] in Blood
147
1334
1.14
0.66
1.5
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
44
1.60
0.65
1.3
2.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
252
1.29
0.64
8.7
5.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
29
1.73
0.64
1.4
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
30
1.67
0.61
5.6
4.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
35
282
1.26
0.59
1.5
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
122
1103
1.14
0.58
4.4
2.3
—
—
—
0
0
(4034850)
10
149
0.67
0.57
11.8
10.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
37
1.63
0.55
1.7
2.1
mmol/l
6.3
6.6
—
6
22
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
(4094501)
16
116
1.39
0.55
1.1
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
38
1.58
0.54
2.7
3.3
mu/l
24.4
16.8
—
6
38
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
161
1.32
0.52
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
453
4419
1.12
0.51
4.5
4.0
mmol/l
1.4
1.3
2.28
415
4047
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
253
1.24
0.49
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
500
1.16
0.44
2.2
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
31
1.62
0.43
8.6
3.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
172
0.75
0.41
1.5
1.9
—
—
—
0
0
(44806420)
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
252
1.20
0.38
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
290
0.82
0.38
1.8
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
89
1.36
0.38
1.8
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
180
1.23
0.36
2.2
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
547
1.13
0.36
2.3
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
15
117
1.29
0.35
1.2
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
134
0.74
0.35
4.3
4.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
137
1.25
0.32
1.7
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
166
1587
1.06
0.26
5.1
5.0
ug/l
9.6
2.6
0.48
153
1433
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
81
0.74
0.24
2.7
2.5
u/ml
4.3
54.5
—
6
76
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
19
221
0.85
0.23
1.7
2.7
u/ml
18.6
41.1
1.22
19
211
(4024509)
5
42
1.19
0.21
1.4
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
2.2
—
6850.0
—
0
11
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
11
0.00
0.21
0.0
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
11
0.00
0.21
0.0
6.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
2.5
—
1.3
—
0
10
(40761535) Cells panel - Urine sediment
35
387
0.90
0.21
5.3
3.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
98
1.23
0.21
1.4
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
5.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
16.1
—
0
12
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.1
—
2.4
—
0
14
(3000330) Specific gravity of Urine by Test strip
21
239
0.87
0.20
4.0
3.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
50
1.20
0.19
2.3
1.2
ug/l
2.0
3.3
—
6
45
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
99
1.22
0.19
1.9
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
111
1.18
0.16
2.2
1.6
iu/l
12.5
7.4
—
6
33
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
97
931
1.05
0.14
2.7
3.0
ug/l
0.8
0.8
0.20
67
637
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
363
1.08
0.14
2.3
2.2
nmol/l
11.7
13.0
0.43
32
321
(1002224) Polysomnography panel
22
199
1.11
0.13
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
94
1.17
0.13
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
74
712
1.05
0.10
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
525
0.95
0.10
2.0
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
99
1017
0.97
0.08
4.7
3.8
kg/l
1.0
1.0
—
10
135
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
74
1.08
0.07
1.0
1.1
—
14.1
—
0
6
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
130
1275
1.03
0.07
3.9
4.4
%
22.3
21.3
0.33
66
620
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
1068
1.03
0.06
4.3
3.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
100
1.10
0.05
2.2
2.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
21
220
0.95
0.03
4.7
3.7
%
49.9
50.5
0.04
21
215
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
122
1.07
0.02
1.5
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
104
1.06
0.01
3.0
4.1
mg/l
24.6
25.8
—
5
64
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
126
0.95
0.00
1.6
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
106
1.04
0.00
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
99
1.01
0.00
2.2
1.9
pmol/l
191.0
237.8
—
10
92
(40768800) Prostate Pathology biopsy report
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
191
0.99
0.00
2.6
3.3
u/ml
68.2
1611.3
1.00
14
163
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.6
—
0
5
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
60.6
—
0
7
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
85
0.94
0.00
1.9
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
100
1.00
0.00
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
60
1.00
0.00
1.3
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
8.0
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
64
0.94
0.00
1.7
1.4
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: D3_EOSINOPHILIA – Eosinophilia

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).